期刊文献+

肿瘤化疗患者预期性呕吐症状影响因素研究 被引量:7

暂未订购
导出
摘要 目的:肿瘤患者化疗时会有预期性呕吐症状,探讨影响预期性呕吐症状的多方面因素,为临床化疗和护理提供良好方案。方法:选取年龄、化疗方案、化疗周期等均不同的患者97例,采用调查问卷方法对患者进行调查,并对其结果进行分析。结果:97例肿瘤患者有60例发生预期性恶心呕吐,发生率为61.9%。患者的情绪、化疗方案、化疗周期及有无化疗呕吐史均对预期性呕吐症状产生影响(P<0.05),另外,年龄、性别亦对其有一定影响。结论:肿瘤患者化疗时,产生预期性呕吐症状几率极高,临床上一定要给予高度重视,做好患者和医院两方面工作,减少化疗的危险性因素,提高化疗水平。
作者 温鸿清
出处 《吉林医学》 CAS 2014年第5期901-903,共3页 Jilin Medical Journal
  • 相关文献

参考文献6

二级参考文献66

共引文献88

同被引文献71

  • 1叶维菲,徐俊冕.“综合性医院焦虑抑郁量表”在综合性医院病人中的应用与评价[J].中国行为医学杂志,1993,2(3):17-19. 被引量:294
  • 2徐文炜,季庆,许伯荣.抑郁发作患者焦虑症状与自杀倾向相关性研究[J].中国行为医学科学,2006,15(1):38-39. 被引量:10
  • 3任婷婷.针刺对胃肠激素影响的研究概况[J].辽宁中医药大学学报,2006,8(6):68-69. 被引量:3
  • 4王霞,张芳,潘芳,于洪鸾.癌症患者预期性恶心和呕吐的不良情绪与应激[J].中国心理卫生杂志,2007,21(8):549-552. 被引量:18
  • 5Chawla SP,Grunberg SM,Gralla RJ,et al. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemothera- py - induced nausea and vomiting [ J ]. Cancer, 2003,97 ( 9 ) : 2290 - 2300.
  • 6De Wit R, Herrstedt J, Rapoport B, et al. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection a- gainst nausea and vomiting during multiple cycles of cisplatin - based chemotherapy [ J ]. J Clin Oncol, 2003,21 ( 22 ) : 4105 - 4111.
  • 7Hesketh PJ, Grunberg SM, Gralla R J, et at. The oral neurokinin - 1 antagonist aprepitant for the prevention of chemotherapy - induced nausea and vomiting: A multinational, randomized, double - blind, placebo - controlled trial in patients receiving high - dose cisplatin -the Aprepitant Protocol 052 Study Group [ J]. J Clin Oncol, 2003,21 (22) :4112 -4119.
  • 8Hu Z, Cheng Y, Zhang H, et al. Aprepitant triple therapy for the prevention of chemotherapy - induced nausea and vomiting follow- ing high - dose cisplatin in Chinese patients : A randomized, double -blind, placebo - controlled phase Ⅲ trial [ J ]. Support Care Cancer,2014,22 (4) :979 - 987.
  • 9Nakayama Y, Ito Y, Tanabe M, et at. A combination of aprepitant, palonosetron, and dexamethasone prevents emesis associated with anthracycline - containing regimens for patients with breast cancer. A retrospective study [ J ]. Breast Cancer, 2013,13 : 472 - 474.
  • 10Poll - Bigelli S, Rodrigues - Perelra J, Carides AD, et at. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antic- merit therapy improves ontrol of chemotherapy - induced nausea and vomiting[ J]. Cancer,2003,97 ( 12 ) :3090 - 3098.

引证文献7

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部